# Oracle Corp: overview

ORCL · NYSE · CIK 1341439 · [Technology](/sectors/technology.md) · fiscal year ends May 31

Pages: [Overview](/companies/orcl.md) · [Financials](/companies/orcl/financials.md) · [Filings](/companies/orcl/filings.md) · [Insiders](/companies/orcl/insiders.md)

Latest reported revenue: [$19.34bn](/filings/0001193125-26-389274.md) for Q1 FY2027, three months to 2026-08-31, from the 10-Q filed Sep 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-389274).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [14.1](/filings/0001193125-25-315925.md) | [14.1](/filings/0001193125-26-101045.md) | [15.9 d](/filings/0001193125-26-277521.md) | [14.9](/filings/0001193125-26-389274.md) | [16.1](/filings/0001193125-25-315925.md) | [17.2](/filings/0001193125-26-101045.md) | [19.2 d](/filings/0001193125-26-277521.md) | [19.3](/filings/0001193125-26-389274.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [30.0%](/filings/0001193125-25-315925.md) | [30.8%](/filings/0001193125-26-101045.md) | [32.1% d](/filings/0001193125-26-277521.md) | [28.7%](/filings/0001193125-26-389274.md) | [29.5%](/filings/0001193125-25-315925.md) | [31.8%](/filings/0001193125-26-101045.md) | [32.0% d](/filings/0001193125-26-277521.md) | [34.8%](/filings/0001193125-26-389274.md) |
| Net margin | % | [22.4%](/filings/0001193125-25-315925.md) | [20.8%](/filings/0001193125-26-101045.md) | [21.5% d](/filings/0001193125-26-277521.md) | [19.6%](/filings/0001193125-26-389274.md) | [38.2%](/filings/0001193125-25-315925.md) | [21.6%](/filings/0001193125-26-101045.md) | [22.4% d](/filings/0001193125-26-277521.md) | [24.6%](/filings/0001193125-26-389274.md) |
| Diluted EPS | $ per share | [1.10](/filings/0001193125-25-315925.md) | [1.02](/filings/0001193125-26-101045.md) | not reported | [1.01](/filings/0001193125-26-389274.md) | [2.10](/filings/0001193125-25-315925.md) | [1.27](/filings/0001193125-26-101045.md) | not reported | [1.56](/filings/0001193125-26-389274.md) |
| Free cash flow | $bn | [(2.7) d](/filings/0001193125-25-315925.md) | [0.1 d](/filings/0001193125-26-101045.md) | [(2.9) d](/filings/0001193125-26-277521.md) | [(0.4)](/filings/0001193125-26-389274.md) | [(10.0) d](/filings/0001193125-25-315925.md) | [(11.5) d](/filings/0001193125-26-101045.md) | [(1.9) d](/filings/0001193125-26-277521.md) | [(5.4)](/filings/0001193125-26-389274.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-05-31) | FY2023 (2023-05-31) | FY2024 (2024-05-31) | FY2025 (2025-05-31) | FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [42.4](/filings/0000950170-24-075605.md) | [50.0](/filings/0000950170-25-087926.md) | [53.0](/filings/0001193125-26-277521.md) | [57.4](/filings/0001193125-26-277521.md) | [67.4](/filings/0001193125-26-277521.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [25.7%](/filings/0000950170-24-075605.md) | [26.2%](/filings/0000950170-25-087926.md) | [29.0%](/filings/0001193125-26-277521.md) | [30.8%](/filings/0001193125-26-277521.md) | [30.6%](/filings/0001193125-26-277521.md) |
| Net margin | % | [15.8%](/filings/0000950170-24-075605.md) | [17.0%](/filings/0000950170-25-087926.md) | [19.8%](/filings/0001193125-26-277521.md) | [21.7%](/filings/0001193125-26-277521.md) | [25.4%](/filings/0001193125-26-277521.md) |
| Diluted EPS | $ per share | [2.41](/filings/0000950170-24-075605.md) | [3.07](/filings/0000950170-25-087926.md) | [3.71](/filings/0001193125-26-277521.md) | [4.34](/filings/0001193125-26-277521.md) | [5.83](/filings/0001193125-26-277521.md) |
| Free cash flow | $bn | [5.0](/filings/0000950170-24-075605.md) | [8.5](/filings/0000950170-25-087926.md) | [11.8](/filings/0001193125-26-277521.md) | [(0.4)](/filings/0001193125-26-277521.md) | [(23.7)](/filings/0001193125-26-277521.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/orcl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.30bn | 145,353,687 |  | Added +2,043,313 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $16.38bn | 111,788,001 |  | Added +672,589 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $11.53bn | 78,645,193 |  | Added +2,342,018 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $8.40bn | 57,285,664 |  | Added +539,987 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $5.82bn | 39,746,237 |  | Added +7,606,983 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.73bn | 39,248,959 |  | Added +300,741 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $4.48bn | 30,551,196 |  | Added +1,418,524 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.81bn | 26,025,909 |  | Added +3,145,069 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $3.66bn | 25,002,553 |  | New +25,002,553 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $3.51bn | 23,954,012 |  | Added +8,570,333 |

## Recent filings

[All 1,823 filings](/companies/orcl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 16:05 ET | [DEF 14A](/filings/0001193125-26-402816.md) | Proxy statement, period 2026-11-18 | 0001193125-26-402816 |
| 2026-09-14 | 06:01 ET | [8-K](/filings/0001193125-26-389753.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389753 |
| 2026-09-11 | 16:10 ET | [10-Q](/filings/0001193125-26-389274.md) | Quarterly report, period 2026-08-31 | 0001193125-26-389274 |
| 2026-09-10 | 16:16 ET | [8-K](/filings/0001193125-26-387905.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387905 |
| 2026-06-22 | 16:12 ET | [10-K](/filings/0001193125-26-277521.md) | Annual report, period 2026-05-31 | 0001193125-26-277521 |
| 2026-06-10 | 16:13 ET | [8-K](/filings/0001193125-26-265848.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-265848 |
| 2026-05-12 | 16:50 ET | [8-K](/filings/0001193125-26-219708.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-219708 |
| 2026-04-06 | 08:12 ET | [8-K](/filings/0001193125-26-142939.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-142939 |
| 2026-03-11 | 06:38 ET | [10-Q](/filings/0001193125-26-101045.md) | Quarterly report, period 2026-02-28 | 0001193125-26-101045 |
| 2026-03-10 | 16:12 ET | [8-K](/filings/0001193125-26-100148.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-100148 |

## Latest annual report

[Form 10-K for the fiscal year ended May 31, 2026](/filings/0001193125-26-277521.md), filed Jun 22, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1341439
- Tickers: ORCL, ORCL-PD
- Exchange: NYSE
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 18:10 ET. No prices; not investment advice.